The Africa Faith and Justice Network (AFJN) and the Advocacy Network for Africa (AdNA) invite you to “The 2026 Ebola Outbreak – Understanding the Crisis” online event on Thursday, June 11, 2026 at 11:00 am ET (Washington, DC). This event is free and open to the public. Registration requested.
The Democratic Republic of Congo is again confronting an Ebola outbreak that has already extended beyond its borders, endangering lives, straining health systems, and deepening vulnerability in already fragile communities. Join us for a special briefing featuring two experts with firsthand experience in Ebola response, infectious disease research, and public health across Africa. Our experts will provide latest updates on the epidemic, discuss ongoing public health efforts and key challenges, and explore how individuals and organizations can respond with informed action, compassion, and purpose.
Pdf versions of sharable fliers:
https://afjn.org/wp-content/uploads/2026/06/2026-ebola-sm.pdf
https://afjn.org/wp-content/uploads/2026/06/2026-ebola.pdf
“The 2026 Ebola Outbreak: Understanding the Crisis“
June 11, 2026
11:00 am EDT (Washington, DC, USA)
8:00 am PDT (Los Angeles, CA, USA)
10:00 am CDT (Chicago, IL, USA)
4:00 pm (Kinshasa, DRC)
5:00 pm (Lubumbashi, DRC)
6:00 pm (Kampala, Uganda)
Zoom link: https://us06web.zoom.us/j/85171895606
If you cannot access the Zoom link, AFJN is also live streaming the event on our AFJN YouTube Channel: https://www.youtube.com/@AfricaFaithandJusticeNetwork/streams
Featured Speakers
Dr. Nsengi Ntamabyaliro, MD, MSc, PhD
Associate Professor, Faculty of Medicine, University of Kinshasa
Dr. Nsengi Ntamabyaliro is Head of the Department of Basic Sciences and Professor of Pharmacology and Pharmacoepidemiology at the University of Kinshasa. He has extensive experience in infectious disease research, pharmacovigilance, and clinical trials in the Democratic Republic of Congo. His work has included service on the pharmacovigilance working group for randomized clinical trials of anti-Ebola therapies, leadership in Mpox drug trial pharmacovigilance, and principal investigatory work on Mpox vaccine safety monitoring. He collaborates with national and international partners on therapeutics, drug safety, and epidemic-prone diseases. (AFJN received permission from Dr. Ntamabyaliro to use the photo.)
Dr. Alice Lamwaka Veronica, PhD
Senior Lecturer, Faculty of Medicine, Department of Pharmacy, Gulu University, Uganda and Public Health Advocate
Dr. Alice Lamwaka Veronica is a Senior Lecturer in the Department of Pharmacy at Gulu University whose work bridges laboratory science, clinical care, and health policy. She chairs the Scientific Committee of the 4th National Test and Treat Initiatives Conference and has led more than fifteen years of community-based research in post-conflict Northern Uganda. Her advocacy centers on African-led, sustainable health solutions that strengthens public health systems and places local expertise at the center of response.
